REG - Morgan Stanley & Co. - Stabilisation Notice

LivanovaAnnouncement

31/01/2022 11:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220131:nRSe1483Aa&default-theme=true

RNS Number : 1483A  Morgan Stanley & Co. Int'l plc  31 January 2022

 

31(st) January 2022

Not for distribution, directly or indirectly, in or into the United States or
any jurisdiction in which such distribution would be unlawful.

 

Cidron Aida Finco S.à r.l.

 

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 17(th) January
2022, Morgan Stanley & Co. International plc, (contact: Mikolaj Zieleznik;
telephone: +44 20 7677-7863) hereby gives notice that no stabilisation (within
the meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014),
including as it forms part of domestic law by virtue of the European Union
(Withdrawal) Act 2018) was undertaken by the Stabilisation Manager(s) named
below in relation to the offer of the following securities.

Securities

 Issuer:                    Cidron Aida Finco S.à r.l.
 Guarantor(s) (if any):     ADVANZ PHARMA HoldCo Limited (formerly known as Cidron Aida Bidco Limited),
                            Amdipharm Limited, Mercury Pharmaceuticals Limited, Advanz Pharma Generics
                            (UK) Limited and Mercury Pharma International Limited;
 Aggregate nominal amount:  EUR 175,000,000 (upsized from initial launch size)
 Description:               Tap of Existing EUR 5% Senior Secured Notes due 2028
 ISIN:                      Permanent ISIN (RegS): XS2325699994

                            Temporary ISIN (RegS): XS2436126242

                            Permanent ISIN (144A): XS2325700081
 Offer price:               99.375

 

 

Stabilisation

 Stabilisation Manager(s):  Morgan Stanley & Co. International plc

 

This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United
States. The securities referred to above have not been, and will not be,
registered under the United States Securities Act of 1933 and may not be
offered or sold in the United States absent registration or an exemption from
registration. There has not been and will not be a public offer of the
securities in the United States.

END.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STABBMMTMTMJBBT